UC Irvine School of Medicine’s Revolutionary iPad Program to Utilize E-Textbooks from Elsevier
First-year med students will access four key titles, including Netter: Atlas of Human Anatomy, from their UCI-furnished iPads
Philadelphia, PA – August 26, 2010 – Elsevier, a world-leading publisher of scientific, technical and medical information products and services, announced today it will provide four key electronic textbook titles for UC Irvine School of Medicine’s new program that gives Apple iPads to its first-year medical students
Elsevier will provide UCI’s incoming medical students with access to Netter: Atlas of Human Anatomy, Gartner: Color Textbook of Histology, Costanzo Physiology and Nussbaum: Thompson & Thompson Genetics in Medicine – all through their new iPads.
“We believe a digitally based curriculum is the future of medical education,” said Dr. Ralph V. Clayman, dean of the UCI School of Medicine. “Our commitment to provide these students with the best technology platform and content available is shared by Elsevier, which has responded quickly and positively to our request for high-quality e-textbooks accessible through the iPad.”
UCI School of Medicine students and faculty will use their iPads to access Student Consult, Elsevier’s online portal where students can access full textbooks plus additional interactive content. Student Consult is where UCI med students will find the four e-textbooks selected for the first term courses. Elsevier will work closely with UCI to monitor the use of the content and the iPads.
“UCI is setting the bar high for how medical schools students and professors should be interacting with medical textbooks,” said Randy Charles, Managing Director for Elsevier’s Global Clinical Reference Group. “We fully support UCI’s progressive move and are working hard to make more of our respected medical content available through mobile devices like the iPad and iPhone.”
UCI anticipates it will add further Elsevier texts as the school year progresses.
Elsevier is a world-leading provider of information solutions that enhance the performance of science, health, and technology professionals, empowering them to make better decisions, deliver better care, and sometimes make groundbreaking discoveries that advance the boundaries of knowledge and human progress. Elsevier provides web-based, digital solutions — among them ScienceDirect, Scopus, Elsevier Research Intelligence,and ClinicalKey—and publishes over 2,200 journals, including The Lancet and Cell, and over 25,000 book titles, including a number of iconic reference works.
The company is part of Reed Elsevier Group PLC, a world leading provider of professional information solutions in the Science, Medical, Legal and Risk and Business sectors, which is jointly owned by Reed Elsevier PLC and Reed Elsevier NV. The ticker symbols are REN (Euronext Amsterdam), REL (London Stock Exchange), RUK and ENL (New York Stock Exchange).Media Contact
Vice President, Global Corporate Relations
+1 215 239 3508